Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Alzheimer's Disease

  Free Subscription


Articles published in Nature

Retrieve available abstracts of 67 articles:
HTML format



Single Articles


    April 2024

  1. A test for Alzheimer's-disease stage predicts dementia risk.
    Nature. 2024;628:11.
    PubMed    


    March 2024
  2. HANEY MS, Palovics R, Munson CN, Long C, et al
    APOE4/4 is linked to damaging lipid droplets in Alzheimer's disease microglia.
    Nature. 2024 Mar 13. doi: 10.1038/s41586-024-07185.
    PubMed     Abstract available


  3. MURDOCK MH, Yang CY, Sun N, Pao PC, et al
    Multisensory gamma stimulation promotes glymphatic clearance of amyloid.
    Nature. 2024;627:149-156.
    PubMed     Abstract available


  4. LANDHUIS E
    Researchers call for a major rethink of how Alzheimer's treatments are evaluated.
    Nature. 2024;627:S18-S20.
    PubMed    


    February 2024
  5. LENHARO M
    Obesity drugs have another superpower: taming inflammation.
    Nature. 2024;626:246.
    PubMed    


    January 2024
  6. KRAMER K
    Daily briefing: New evidence supports controversial hypothesis of 'transmissible' Alzheimer's.
    Nature. 2024 Jan 30. doi: 10.1038/d41586-024-00282.
    PubMed    


  7. GRAHAM F
    Daily briefing: Drugs such as Ozempic could help with Alzheimer's and Parkinson's.
    Nature. 2024 Jan 29. doi: 10.1038/d41586-024-00272.
    PubMed    


  8. WONG C
    Signs of 'transmissible' Alzheimer's seen in people who received growth hormone.
    Nature. 2024 Jan 29. doi: 10.1038/d41586-024-00268.
    PubMed    


  9. LOVESTAM S, Li D, Wagstaff JL, Kotecha A, et al
    Disease-specific tau filaments assemble via polymorphic intermediates.
    Nature. 2024;625:119-125.
    PubMed     Abstract available


  10. IRVING-PEASE EK, Refoyo-Martinez A, Barrie W, Ingason A, et al
    The selection landscape and genetic legacy of ancient Eurasians.
    Nature. 2024;625:312-320.
    PubMed     Abstract available


    December 2023
  11. THOMPSON T
    How CRISPR gene editing could help treat Alzheimer's.
    Nature. 2023 Dec 11. doi: 10.1038/d41586-023-03931.
    PubMed    


  12. OH HS, Rutledge J, Nachun D, Palovics R, et al
    Organ aging signatures in the plasma proteome track health and disease.
    Nature. 2023;624:164-172.
    PubMed     Abstract available


    November 2023
  13. KOZLOV M
    AI that reads brain scans shows promise for finding Alzheimer's genes.
    Nature. 2023 Nov 10. doi: 10.1038/d41586-023-03482.
    PubMed    


    October 2023
  14. REARDON S
    The brain cells linked to protection against dementia.
    Nature. 2023;622:229-230.
    PubMed    


    September 2023
  15. KRAMER K
    Daily briefing: Alzheimer's makes brain cells undergo 'cellular suicide'.
    Nature. 2023 Sep 19. doi: 10.1038/d41586-023-02965.
    PubMed    


    August 2023
  16. REARDON S
    Alzheimer's drug trials plagued by lack of racial diversity.
    Nature. 2023 Aug 2. doi: 10.1038/d41586-023-02464.
    PubMed    


    July 2023
  17. GRAHAM F
    Daily briefing: Abnormal protein levels could be an early hallmark of Alzheimer's disease.
    Nature. 2023 Jul 24. doi: 10.1038/d41586-023-02418.
    PubMed    


  18. REARDON S
    Alzheimer's drug donanemab helps most when taken at earliest disease stage, study finds.
    Nature. 2023 Jul 17. doi: 10.1038/d41586-023-02321.
    PubMed    


    May 2023
  19. DEPP C, Sun T, Sasmita AO, Spieth L, et al
    Myelin dysfunction drives amyloid-beta deposition in models of Alzheimer's disease.
    Nature. 2023 May 31. doi: 10.1038/s41586-023-06120.
    PubMed     Abstract available


  20. REARDON S
    How one man's rare Alzheimer's mutation delayed the onset of disease.
    Nature. 2023 May 15. doi: 10.1038/d41586-023-01610.
    PubMed    


  21. REARDON S
    Alzheimer's drug donanemab: what promising trial means for treatments.
    Nature. 2023 May 4. doi: 10.1038/d41586-023-01537.
    PubMed    


    April 2023
  22. ABBOTT A, Thompson B
    Audio long read: Conquering Alzheimer's - a look at the therapies of the future.
    Nature. 2023 Apr 28. doi: 10.1038/d41586-023-01351.
    PubMed    


  23. ABBOTT A
    Conquering Alzheimer's: a look at the therapies of the future.
    Nature. 2023;616:26-28.
    PubMed    


    March 2023
  24. GULDNER IH, Wyss-Coray T
    Activated immune cells drive neurodegeneration in an Alzheimer's model.
    Nature. 2023 Mar 8. doi: 10.1038/d41586-023-00600.
    PubMed    


  25. CHEN X, Firulyova M, Manis M, Herz J, et al
    Microglia-mediated T cell infiltration drives neurodegeneration in tauopathy.
    Nature. 2023;615:668-677.
    PubMed     Abstract available


    February 2023
  26. REIMAN EM
    Drug trial for Alzheimer's disease is a game changer.
    Nature. 2023 Feb 13. doi: 10.1038/d41586-023-00393.
    PubMed    


  27. MARTIN-PENA A, Tansey MG
    The Alzheimer's risk gene APOE modulates the gut-brain axis.
    Nature. 2023 Feb 6. doi: 10.1038/d41586-023-00261.
    PubMed    


    January 2023
  28. ELSE H
    Alzheimer's drug saga prompts journal to scrutinize whistle-blowers.
    Nature. 2023 Jan 12. doi: 10.1038/d41586-023-00050.
    PubMed    


  29. REARDON S
    FDA approves Alzheimer's drug lecanemab amid safety concerns.
    Nature. 2023;613:227-228.
    PubMed    


    November 2022
  30. PRILLAMAN M
    Heralded Alzheimer's drug works - but safety concerns loom.
    Nature. 2022 Nov 30. doi: 10.1038/d41586-022-04240.
    PubMed    


  31. YUAN P, Zhang M, Tong L, Morse TM, et al
    PLD3 affects axonal spheroids and network defects in Alzheimer's disease.
    Nature. 2022 Nov 30. doi: 10.1038/s41586-022-05491.
    PubMed     Abstract available


  32. COBOS I, Palop JJ
    Swollen axons impair neuronal circuits in Alzheimer's disease.
    Nature. 2022 Nov 30. doi: 10.1038/d41586-022-03800.
    PubMed    


  33. GRAHAM F
    Daily briefing: How an Alzheimer's gene ravages the brain.
    Nature. 2022 Nov 17. doi: 10.1038/d41586-022-03780.
    PubMed    


  34. WAGNER J, Degenhardt K, Veit M, Louros N, et al
    Medin co-aggregates with vascular amyloid-beta in Alzheimer's disease.
    Nature. 2022 Nov 16. pii: 10.1038/s41586-022-05440.
    PubMed     Abstract available


  35. DOLGIN E
    This is how an Alzheimer's gene ravages the brain.
    Nature. 2022 Nov 16. pii: 10.1038/d41586-022-03724.
    PubMed    


  36. PETRIC HOWE N, Thompson B
    How a key Alzheimer's gene wreaks havoc in the brain.
    Nature. 2022 Nov 16. pii: 10.1038/d41586-022-03746.
    PubMed    


  37. CARLSTROM K, Castelo-Branco G
    Alzheimer's risk variant APOE4 linked to myelin-assembly malfunction.
    Nature. 2022 Nov 16. pii: 10.1038/d41586-022-03371.
    PubMed    


  38. BLANCHARD JW, Akay LA, Davila-Velderrain J, von Maydell D, et al
    APOE4 impairs myelination via cholesterol dysregulation in oligodendrocytes.
    Nature. 2022;611:769-779.
    PubMed     Abstract available


  39. DRIEU A, Du S, Storck SE, Rustenhoven J, et al
    Parenchymal border macrophages regulate the flow dynamics of the cerebrospinal fluid.
    Nature. 2022;611:585-593.
    PubMed     Abstract available


    October 2022
  40. YANG Y, Shi Y, Schweighauser M, Zhang X, et al
    Structures of alpha-synuclein filaments from human brains with Lewy pathology.
    Nature. 2022;610:791-795.
    PubMed     Abstract available


    September 2022
  41. PRILLAMAN M
    Alzheimer's drug slows mental decline in trial - but is it a breakthrough?
    Nature. 2022 Sep 29. pii: 10.1038/d41586-022-03081.
    PubMed    


    July 2022
  42. NAIK S, Fuchs E
    Inflammatory memory and tissue adaptation in sickness and in health.
    Nature. 2022;607:249-255.
    PubMed     Abstract available


  43. ZHOU Y, Su Y, Li S, Kennedy BC, et al
    Molecular landscapes of human hippocampal immature neurons across lifespan.
    Nature. 2022;607:527-533.
    PubMed     Abstract available


    June 2022
  44. KARLAWISH J
    Fix the process that led to Alzheimer's drug fiasco.
    Nature. 2022;606:9.
    PubMed    


    May 2022
  45. KOZLOV M
    Will the FDA change how it vets drugs following the Alzheimer's debacle?
    Nature. 2022 May 13. pii: 10.1038/d41586-022-01316.
    PubMed    


    April 2022
  46. MILLER MB, Huang AY, Kim J, Zhou Z, et al
    Somatic genomic changes in single Alzheimer's disease neurons.
    Nature. 2022 Apr 20. pii: 10.1038/s41586-022-04640.
    PubMed     Abstract available


    March 2022
  47. STEWART L
    The coin toss of Alzheimer's inheritance.
    Nature. 2022 Mar 17. pii: 10.1038/d41586-022-00659.
    PubMed    


  48. XIONG J, Kang SS, Wang Z, Liu X, et al
    FSH blockade improves cognition in mice with Alzheimer's disease.
    Nature. 2022 Mar 2. pii: 10.1038/s41586-022-04463.
    PubMed     Abstract available



  49. A pituitary hormone has a key role in Alzheimer's disease.
    Nature. 2022 Mar 2. pii: 10.1038/d41586-022-00530.
    PubMed    


  50. ABBOTT A
    Could drugs prevent Alzheimer's? These trials aim to find out.
    Nature. 2022;603:216-219.
    PubMed    


    February 2022
  51. YANG AC, Vest RT, Kern F, Lee DP, et al
    A human brain vascular atlas reveals diverse mediators of Alzheimer's risk.
    Nature. 2022 Feb 14. pii: 10.1038/s41586-021-04369.
    PubMed     Abstract available



  52. Molecular map of the human blood-brain barrier reveals links to Alzheimer's disease.
    Nature. 2022 Feb 14. pii: 10.1038/d41586-022-00350.
    PubMed    


    December 2021
  53. DE MIGUEL Z, Khoury N, Betley MJ, Lehallier B, et al
    Exercise plasma boosts memory and dampens brain inflammation via clusterin.
    Nature. 2021;600:494-499.
    PubMed     Abstract available


    November 2021
  54. ROBINSON A
    Defining Alzheimer's, and the climate costs of AI: Books in brief.
    Nature. 2021 Nov 19. pii: 10.1038/d41586-021-03484.
    PubMed    


  55. MULLARD A
    More Alzheimer's drugs head for FDA review: what scientists are watching.
    Nature. 2021 Nov 15. pii: 10.1038/d41586-021-03410.
    PubMed    


    October 2021
  56. STAHLBERG H, Riek R
    Structural strains of misfolded tau protein define different diseases.
    Nature. 2021;598:264-265.
    PubMed    


  57. BERG J, Sorensen SA, Ting JT, Miller JA, et al
    Human neocortical expansion involves glutamatergic neuron diversification.
    Nature. 2021;598:151-158.
    PubMed     Abstract available


    July 2021
  58. BARRON JJ, Molofsky AV
    A protective signal between the brain's supporting cells in Alzheimer's disease.
    Nature. 2021 Jul 14. pii: 10.1038/d41586-021-01870.
    PubMed    


  59. MCALPINE CS, Park J, Griciuc A, Kim E, et al
    Astrocytic interleukin-3 programs microglia and limits Alzheimer's disease.
    Nature. 2021 Jul 14. pii: 10.1038/s41586-021-03734.
    PubMed     Abstract available


    June 2021
  60. MULLARD A
    Controversial Alzheimer's drug approval could affect other diseases.
    Nature. 2021 Jun 29. pii: 10.1038/d41586-021-01763.
    PubMed    


  61. GRAHAM F
    Daily briefing: Alzheimer's drug controversially approved by FDA.
    Nature. 2021 Jun 8. pii: 10.1038/d41586-021-01553.
    PubMed    


  62. MULLARD A
    Landmark Alzheimer's drug approval confounds research community.
    Nature. 2021 Jun 8. pii: 10.1038/d41586-021-01546.
    PubMed    


    May 2021
  63. ABASCAL F, Harvey LMR, Mitchell E, Lawson ARJ, et al
    Somatic mutation landscapes at single-molecule resolution.
    Nature. 2021;593:405-410.
    PubMed     Abstract available


  64. DA MESQUITA S, Papadopoulos Z, Dykstra T, Brase L, et al
    Meningeal lymphatics affect microglia responses and anti-Abeta immunotherapy.
    Nature. 2021;593:255-260.
    PubMed     Abstract available


    February 2021
  65. WILLYARD C
    How gut microbes could drive brain disorders.
    Nature. 2021;590:22-25.
    PubMed    


    January 2021
  66. ELSE H
    The science events to watch for in 2021.
    Nature. 2021;589:14-15.
    PubMed    


    November 2020
  67. ABBOTT A
    Are infections seeding some cases of Alzheimer's disease?
    Nature. 2020;587:22-25.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.